Comparison of Prognostic Importance of Latest CD4+ Cell Count and HIV RNA Levels in Patients with Advanced HIV Infection on Highly Active Antiretroviral Therapy

REFERENCES

• Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167–1170.
   PubMed Web of Science ®Google Scholar
• CASCADE Collaboration. Short-term risk of AIDS accord-ing to current CD4 cell count and viral load in antiretroviral drug-naïve individuals and those treated in the monotherapy era. AIDS. 2004;18:51–58.
   PubMed Web of Science ®Google Scholar
• Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119–129.
   PubMed Web of Science ®Google Scholar
• Lederberger B, Egger M, Erard V, et al. AIDS-related op-portunistic illnesses occurring after initiation of potent antiretroviral therapy. The Swiss HIV Cohort Study. JAMA. 1999;282:2220–2226.
   PubMed Web of Science ®Google Scholar
• Miller V, Staszewski S, Nisius G, et al. Risk of new AIDS diseases in people on triple therapy [letter]. Lancet. 1999;353:463.
   PubMed Web of Science ®Google Scholar
• Binquet C, Chene G, Jacqmin-Gadda H, et al. Modeling changes in CD4+-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996–1997. Am J EpidemioL 2001153: 386–393.
   Google Scholar
• Hogg RS, Yip B, Chan KJ, et al. Rates of disease progres-sion by baseline CD4+ cell count and viral load after initiat-ing triple-drug therapy. JAMA. 2001;286:2568–2577.
   PubMed Web of Science ®Google Scholar
• Sterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4+ T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS. 2001;15:2251–2257.
   PubMed Web of Science ®Google Scholar
• van Sighem Al, van de Wiel MA, Ghani AC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS. 2003;17:2259–2260.
   PubMed Web of Science ®Google Scholar
• Miller V, Sabin CA, Phillips AN, et al. The impact of pro-tease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4+ and viral load. AIDS. 2000;14:2129–2136.
   PubMed Web of Science ®Google Scholar
• Kaplan JE, Hanson DL, Jones JL, Dworkin MS, and the Adult and Adolescent Spectrum of HIV Disease Project Investigators. Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adoles-cents. AIDS. 2001;15:1831–1836.
   PubMed Web of Science ®Google Scholar
• Lewden C, Raffi F, Cuzin L, et al. Factors associated with mortality in human immunodeficiency virus type l-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 Study). J Infect Dis. 2002;186:710–714.
   PubMed Web of Science ®Google Scholar
• Lundgren JD, Mocroft A, Gatell JM, et al. A clinically prog-nostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA Study. J Infect Dis. 2002;185:178–187.
   PubMed Web of Science ®Google Scholar
• Miller V, Phillips AN, Clotet B, et al. Association of virus load, CD4 cell count, and treatment with clinical progres-sion in human immunodeficiency virus-infected patients with very low CD4 cell counts. J Infect Dis. 2002;186:189–197.
   PubMed Web of Science ®Google Scholar
• The Antiretroviral Therapy (ART) Cohort Collaboration. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet. 2003;362:679–686.
   PubMed Web of Science ®Google Scholar
• Anastos K, Barrón Y, Cohen MH, et al. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Ann Intern Med. 2004;140:256–264.
   PubMed Web of Science ®Google Scholar
• Perez G, MacArthur RD, Walmsley S, et al. A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102). HIV Clin Trials. 2004;5:7–18.
   PubMed Web of Science ®Google Scholar
• Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin MicrobioL 1994;32:292–300.
   PubMed Web of Science ®Google Scholar
• Green LA, Rhame FS, Price RW, et al. Experience with a cross-study endpoint review committee for AIDS clinical trials. AIDS. 1998;12:1983–1990.
   PubMed Web of Science ®Google Scholar
• Cox DR. Regression models and life-tables. J Roy Stat Soc Ser B. 1972;34:187–220.
   Google Scholar
• Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet. 2000; 356:291–296.
   PubMed Web of Science ®Google Scholar
• The PLATO Collaboration. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virologic failure to all three antiretroviral-drug classes. Lancet. 2004;364:51–62.
   PubMed Web of Science ®Google Scholar
• HIV Surrogate Marker Collaborative Group. Human immu-nodeficiency virus type 1 RNA level and CD4+ cell count as prognostic markers and surrogate end points: a meta-analysis. AIDS Res Hum Retro viruses. 2000;16:1123–1133.
   PubMed Web of Science ®Google Scholar
• Phillips AN, Staszewski S, Weber R, et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA. 2001;286:2597–2599.
   PubMed Web of Science ®Google Scholar
• Hennessey KA, Giorgi JV, Kaplan AH, et al. AIDS onset at high CD4+ cell levels is associated with high viral load. AIDS Res Hum Retroviruses. 2000;16:103–107.
   PubMed Web of Science ®Google Scholar
• Lederman MM, Valdez H. Immune restoration with antiretroviral therapies. Implications for clinical manage-ment. JAMA. 2000;284:223–228.
   PubMed Web of Science ®Google Scholar